Barinthus Biotherapeutics plc (BRNS)
Sep 9, 2026 - BRNS was delisted (reason: merged with CLYD)
0.7401
0.00 (0.00%)
Inactive · Last trade price on Sep 8, 2026
Barinthus Biotherapeutics Employees
Barinthus Biotherapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 91 or -86.67% compared to the previous year.
Employees
14
Change (1Y)
-91
Growth (1Y)
-86.67%
Revenue / Employee
n/a
Profits / Employee
-$2,983,357
Market Cap
30.23M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | -91 | -86.67% |
| Dec 31, 2024 | 105 | -25 | -19.23% |
| Dec 31, 2023 | 130 | 23 | 21.50% |
| Dec 31, 2022 | 107 | 35 | 48.61% |
| Dec 31, 2021 | 72 | 24 | 50.00% |
| Mar 31, 2021 | 49 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
BRNS News
- 4 weeks ago - Barinthus Bio Provides Update on Proposed Combination with Clywedog Therapeutics - GlobeNewsWire
- 7 weeks ago - Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments - GlobeNewsWire
- 7 weeks ago - Barinthus Biotherapeutics Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Barinthus Biotherapeutics Earnings release: Q2 2026 - Filings
- 3 months ago - Barinthus Biotherapeutics Proxy statement: Proxy filing - Filings
- 4 months ago - Barinthus Biotherapeutics Proxy statement: Proxy filing - Filings
- 4 months ago - Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments - GlobeNewsWire
- 4 months ago - Barinthus Biotherapeutics Earnings release: Q1 2026 - Filings